{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:05:59Z","timestamp":1793840759282,"version":"4.6.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2015,8,27]]},"DOI":"10.2174\/1871530315666150316124019","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T05:31:35Z","timestamp":1441171895000},"page":"196-205","source":"Crossref","is-referenced-by-count":396,"title":["Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect"],"prefix":"10.2174","volume":"15","author":[{"given":"Yoshifumi","family":"Saisho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Endocrine, Metabolic &amp; Immune Disorders-Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/129546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T13:22:09Z","timestamp":1447852929000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-5303&volume=15&issue=3&spage=196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,27]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530315666150316124019","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8,27]]}}}